Kerato, a subsidiary of BSF Enterprise and a sister company of 3D Bio-Tissues, has developed the world’s most advanced bio-engineered, biomimetic cornea for medical and research applications.

 

Our proprietary platform technology allows the fabrication of a fully biosynthetic human cornea in-vitro medical device that reproduces the highly complex nanostructure, molecular composition, shape, transparency, and functional properties of the native human-corneal stroma.

 

It provides a cost effective and sustainable solution supporting better patient outcomes, essential research and complimentary markets.